BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17126396)

  • 1. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
    Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
    Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo distribution of c-myc antisense oligodeoxynucleotides local delivered by gelatin-coated platinum-iridium stents in rabbits and its effect on apoptosis.
    Zhang XX; Cui CC; Xu XG; Hu XS; Fang WH; Kuang BJ
    Chin Med J (Engl); 2004 Feb; 117(2):258-63. PubMed ID: 14975213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.
    Lewis AL; Willis SL; Small SA; Hunt SR; O'byrne V; Stratford PW
    Biomed Mater Eng; 2004; 14(4):355-70. PubMed ID: 15472385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
    Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
    Kipshidze NN; Iversen P; Kim HS; Yiazdi H; Dangas G; Seaborn R; New G; Tio F; Waksman R; Mehran R; Tsapenko M; Stone GW; Roubin GS; Iyer S; Leon MB; Moses JW
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):518-27. PubMed ID: 15065150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.
    New G; Moses JW; Roubin GS; Leon MB; Colombo A; Iyer SS; Tio FO; Mehran R; Kipshidze N
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):266-71. PubMed ID: 12357534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model.
    Kipshidze NN; Porter TR; Dangas G; Yazdi H; Tio F; Xie F; Hellinga D; Fournadjiev J; Wolfram R; Seabron R; Waksman R; Abizaid A; Roubin G; Iyer S; Leon MB; Moses JW; Iversen P
    Cardiovasc Radiat Med; 2003; 4(3):152-9. PubMed ID: 14984716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents.
    Prasad CK; Resmi KR; Krishnan LK; Vaishnav R
    J Biomater Appl; 2005 Apr; 19(4):271-86. PubMed ID: 15788425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: long-term results in an animal model using the TriMaxx stent.
    Dubé H; Clifford AG; Barry CM; Schwarten DE; Schwartz LB
    J Vasc Surg; 2007 Apr; 45(4):821-7. PubMed ID: 17398392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted vascular delivery of antisense molecules using intravenous microbubbles.
    Porter TR; Xie F; Knapp D; Iversen P; Marky LA; Tsutsui JM; Maiti S; Lof J; Radio SJ; Kipshidze N
    Cardiovasc Revasc Med; 2006; 7(1):25-33. PubMed ID: 16513520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
    Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
    Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
    Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
    Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
    Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films.
    Zhang Z; Cao X; Zhao X; Withers SB; Holt CM; Lewis AL; Lu JR
    Biomacromolecules; 2006 Mar; 7(3):784-91. PubMed ID: 16529415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.
    Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM
    J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrigel-coated stents reduce intimal thickening in a large animal vascular stent model.
    Tso C; Skinner MP; Hawthorne WJ; Fletcher JP
    Int Angiol; 2002 Sep; 21(3):244-9. PubMed ID: 12384645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.